Back

Initial triple low-dose combination therapy improves blood pressure control without increased adverse events: a systematic review and meta-analysis

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Triple therapy in hypertension Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jong Seon Park

Dongguk University International Hospital, Goyang (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Sex differences in response to triple single-pill combinations for hypertension: a secondary analysis of the OPTION TREAT Trial
Doctor P. Guimaraes (Sao Paulo, BR)
Abstract
Presentation thumbnail
Treatment escalation beyond triple therapy in patients with resistant hypertension: a population-based observational cohort study from UK healthcare records
Doctor P. Swift (London, GB)
Abstract
Presentation thumbnail
Impact of baseline cardiovascular risk on hypertension treatment with a novel triple single-pill: a subanalysis of the OPTION TREAT Trial
Doctor V. Madrini (Sao Paulo, BR)
Abstract
Presentation thumbnail
Efficacy and safety of intensive versus standard systolic blood pressure treatment: A systematic review and meta-analysis
Associate Professor O. Rueda Ochoa (Bucaramanga, CO)
Abstract
Presentation thumbnail
Racial differences on treatment response to triple single-pill combinations for hypertension: a secondary analysis of the OPTION TREAT Trial
Doctor V. Madrini (Sao Paulo, BR)
Abstract

Access the full session

Session thumbnail
Triple therapy in hypertension

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
The safety and efficacy of quadruple ultra-low-dose combination (quadpill) for hypertension treatment: a meta-analysis of randomized controlled trials
27 August 2023
thumbnail
Congress Presentation
Assessing blood pressure control and antihypertensive therapy in patients with hypertension: a comparison with one-year medical records data in Bulgaria (SNAPSHOT study)
25 April 2024
thumbnail
Congress Presentation
Effect of glucagon-like peptide-1 receptor agonists on blood pressure: a systematic review and meta-analysis
4 April 2025
thumbnail
Congress Presentation
Long-term outcomes in newly diagnosed pulmonary arterial hypertension (PAH) patients receiving initial triple oral combination therapy: Insights from the randomised controlled TRITON study
29 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources